US › Healthcare

High Tide Inc (HITI)

US · Healthcare · Pharmaceutical Retailers

$2.57+0.39%

Last close · 2026-10-16

Latest quarter · ended 2026-07-31

Revenue

$201.0M

Revenue YoY

+34.3%

Net profit

$11.4M

Profit YoY

+1809.0%

EPS

$0.02

EPS estimate

$0.01

Net margin

5.7%

EPS came in at 0.02 against a street estimate of 0.01 — a beat of 100.0%.

Key statistics

Market cap

$229.1M

Forward P/E

20.0

P/B

3.23

Book value

$0.83

EPS (TTM)

$-0.31

52-week high

$3.50

52-week low

$2.02

50-day MA

$2.56

200-day MA

$2.43

Beta

0.95

Analyst view

Analysts rate High Tide Inc a strong buy (7 buy, 0 hold, 0 sell out of 7) with an average price target of $4.67.

Shareholding

Insiders

12.17%

Institutions

8.85%

Largest institutional holders

Fund	Stake
Tidal Investments LLC.	1.89%
AdvisorShares Investments, LLC	1.34%
Renaissance Technologies Corp	1.02%
Two Sigma Investments LLC	0.75%
Federation des caisses Desjardins du Quebec	0.30%
Baader Bank INC	0.28%
Millennium Management LLC	0.28%
Ewing Morris & Co Investment Partners Ltd	0.27%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for High Tide Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.